Review article · 26 Feb 2026
CommentaryPublished 29 May 2025
Evolving ADPKD Management: Tolvaptan and Beyond
Subjects
Nephrology & UrologySimilar by topic
Research article · 12 Nov 2021
Delivery of a Tolvaptan (JINARC) Service for Adults with Autosomal Dominant Polycystic Kidney Disease (ADPKD) in a UK Renal Centre
Review article · 17 Sep 2018
New Options in ADPKD and How to Use them–the PROPKD Score and Beyond
Letter · 2016
Use of Tolvaptan beyond Thirty Days in a Case of Refractory SIADH
Conference abstract · 2018
Advances in management of autosomal dominant polycystic kidney disease (ADPKD)
More from this journal
The newest in Journal of Nephrology & Therapeutics.
Research article · 15 Apr 2026
Anemia Management in Hemodialysis Patients in a Low-resource Setting: Blood Transfusion and Unmet Blood Needs in Burkina Faso
Brief report · 30 Mar 2026
Renal Fibrosis: Targeting Pathways For New Therapies
Brief report · 30 Mar 2026
SGLT2 Inhibitors: A New Era for Diabetic Kidney Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology & Therapeutics
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Maria L. Costa”

